Latest news
Hopstem’s iPSC-Derived hNPC01 Cell Therapy Gains FDA Clearance to Target Three Major Brain Injury Indications - BioInformantBioInformant · Wed, 05 Aug 2026 21:57:41 GMTWhat is Lab-Grown Meat and Why Does It Matter? - BioInformantBioInformant · Tue, 04 Aug 2026 07:00:00 GMTChina’s First Approved MSC Therapy, Ruibosheng, Hits the Market at a Fraction of Global Pricing - BioInformantBioInformant · Mon, 03 Aug 2026 07:00:00 GMTThe Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformantBioInformant · Sun, 02 Aug 2026 07:00:00 GMT